2025 International Congress Archives - Page 108 of 181

Modified Delphi consensus approach to develop recommendations for diagnosis, evaluation and management of cognitive disorders in Parkinson’s disease

D. Pourzinal, D. Brooks, D. Sriram, L. Mitchell, N. Pachana, K. Shrubsole, B. Wood, J. O'Sullivan, R. Marsh, A. Lehn, J. Liddle, E. Tan, WK. Halford, N. Page, N. Dissanayaka (HERSTON, Australia)
Modified Timed Up and Go test as a marker for motor improvement in advanced Parkinson’s disease after in-patient multimodal intensive neurorehabilitation and care

M. Mccrossin, F. Avantaggiato, E. Cipparonne, L. Rubin, A. Di Rocco (Glen Cove, USA)
Modifiers of Parkinson’s disease associated with mutations in the GBA1 gene based on transcriptome data validation

A. Bezrukova, K. Basharova, I. Miliukhina, S. Pchelina, T. Usenko (Gatchina, Russian Federation)
Modifying Effect of a Long-term Repeated Therapy of repetitive Transcranial Magnetic Stimulation combined with Lidocaine Injection (rTMS-LI) on Dystonia

N. Murase, R. Urushihara, S. Matsumoto, K. Sato, K. Asanuma, H. Shimazu, R. Kaji (Nara city, Japan)
Modulation of working memory in prodromal DLB by non-invasive brain stimulation of the striatum and cerebellum

I. Rektorová, M. Pupikova, . Gajdoš (Brno, Czech Republic)
Molecular Studies Reveal Overactive Interferon (IFN) Pathway in Two Monogenic Inherited Dystonia Types.

S. Avula, E. Swager, R. Patel (Columbia, USA)
Monitoring Parkinson’s Disease in the Dental Chair

J. Schwartz, L. Dibenedetto, P. Engen, V. Ha, B. Killinger, C. Soto, S. Green, A. Naqvi, S. Tomar, M. Shaikh, M. Villanueva, D. Sanchez-Bass, C. Noh, R. Voigt, C. Goetz, A. Keshavarzian (Chicago, USA)
Monogenic Parkinson’s Disease patients in Central Europe within the CEGEMOD consortium

M. Ostrozovicova, G. Tamas, P. Dusek, M. Grofik, V. Han, P. Holly, R. Jech, P. Klivenyi, N. Kovacs, E. Kurca, A. Lackova, J. Necpal, D. Pinter, E. Ruzicka, T. Serranova, K. Smilowska, I. Straka, T. Svorenova, P. Valkovic, K. Zarubova, H. Houlden, M. Rizig, M. Skorvanek (Kosice, Slovakia)
Morbidity and Mortality Associated with Aspiration Pneumonia: Nationwide Trends in Inpatient Therapy Utilization in Parkinson’s Disease Hospitalization

T. Mehta, H. Kamo, R. Burke, M. Rem, M. Okun, C. Hess (Gainesville, USA)
Mortality and Institutionalisation Following de Novo Use of Rotigotine Patches in Hospitalised Patients with Parkinson’s Disease

E. Kaye, K. Millington, R. Skelly (Nottingham, United Kingdom)